CHE - NYSE
Chemed Corporation
$426.86
-0.030%Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
At a Glance
Live SnapshotChemed Corporation Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Declining FCF warrants attention. Investigate whether due to temporary factors or fundamental deterioration.
Working Capital Impact
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Cash Flow Quality Insight
Asset-light with strong cash conversion: Low capital requirements combined with efficient cash generation creates significant shareholder value through dividends, buybacks, or strategic investments.
Chemed Corporation Cash Flow Statement
CHE • NYSE
| Chemed Corporation Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
265.2M | 302M | 272.5M | 249.6M | 268.6M | 319.5M | 219.9M | 205.5M | 98.2M | 108.7M | 110.3M | 99.3M | 77.2M | 89.3M | 86M | 81.8M | 73.8M | 71M | 64M | 50.7M | |
64.8M | 63M | 60.9M | 59.2M | 59.1M | 56.6M | 45.2M | 38.9M | 35.6M | 34.6M | 33.5M | 33.1M | 32.4M | 30.5M | 29.5M | 29M | 27.9M | 27.5M | 26.6M | 23.8M | |
-5.9M | -4.1M | -8M | -3.3M | -15.8M | 37.8M | -2.8M | 5.2M | 2.4M | -6.7M | 6.3M | 7M | -7M | -3.2M | 7.2M | -2.4M | 5M | 426K | 8.1M | 7.4M | |
4.9M | 32M | 30.1M | 26.3M | 22.5M | 18.4M | 14.8M | 446K | 1.2M | 1.9M | 2.6M | 10.3M | 10.9M | 12M | 8.4M | 7.8M | 8.6M | 7.3M | 0.0 | 0.0 | |
35.5M | 16.4M | 14.2M | 11.7M | 1.1M | 12.6M | 16.5M | 7.3M | 29M | 13.7M | 9.1M | 16.3M | 19.1M | 15.7M | 16.6M | 18M | 20.8M | 15.1M | 18.8M | 22.7M | |
23.7M | 8.1M | -39.3M | -33.5M | -26.8M | 44.4M | 7.6M | 17.2M | -14.5M | -25.2M | 4.8M | -49.7M | 23.1M | -8.7M | 26.7M | -48.2M | 24.4M | -4.6M | -20.2M | -6M | |
388.3M | 417.5M | 330.3M | 309.9M | 308.6M | 489.3M | 301.2M | 287.1M | 162.5M | 135.4M | 171.5M | 110.3M | 150.8M | 131.8M | 174.3M | 86M | 160.8M | 112.1M | 99.6M | 98.6M | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-62.8M | -49.5M | -56.9M | -57.3M | -58.7M | -58.8M | -53M | -52.9M | -64.3M | -39.8M | -44.1M | -43.6M | -29.3M | -35.3M | -29.6M | -25.6M | -21.5M | -26.1M | -26.6M | -22M | |
-225K | -97.4M | -4M | -3.5M | (0.0) | -3.6M | -138M | -53.2M | -4.7M | (0.0) | -6.6M | -250K | -2.3M | -5.9M | -3.7M | -9.5M | -1.9M | -11.2M | -1.1M | -4.1M | |
3.7M | 3M | 206K | 1.5M | 918K | 871K | 272K | 824K | 1.4M | -90K | 432K | 294K | 235K | 468K | -858K | -592K | 573K | 8.7M | -4M | -1.6M | |
-59.3M | -143.9M | -60.6M | -59.4M | -57.8M | -61.6M | -190.8M | -105.2M | -67.6M | -39.9M | -50.3M | -43.5M | -31.3M | -40.7M | -34.1M | -35.7M | -22.8M | -28.6M | -31.7M | -27.7M | |
FINANCING ACTIVITIES | ||||||||||||||||||||
-404.3M | -361.4M | -67.7M | -114.5M | -576M | -175.6M | -92.6M | -158.9M | -94.6M | -102.3M | -59.3M | -110M | -92.9M | -60.6M | -144M | -109.3M | -4.2M | -69.8M | -131.7M | -16M | |
11M | -15.7M | -81.8M | -99.4M | 196.9M | -90M | 800K | -13.5M | -850K | 16.8M | -57.4M | -29.7M | -11.4M | 1.9M | -826K | -581K | -20M | -11.4M | 18.3M | -82M | |
-31.7M | -27.1M | -23.5M | -22M | -22M | -21.1M | -19.8M | -18.7M | -17.4M | -16.4M | -15.6M | -14.3M | -14.1M | -13M | -12.5M | -11.9M | -8.2M | -5.5M | -5.9M | -6.3M | |
-431.5M | -361.4M | -67.7M | -114.5M | -576M | -175.6M | -92.6M | -158.9M | -94.6M | -102.3M | -59.3M | -110M | -92.9M | -60.6M | -147.9M | -109.3M | -4.2M | -69.8M | -131.7M | -19.9M | |
-7.7M | 45M | 93.1M | 26.7M | 20.6M | 15.5M | 2.5M | 2.9M | 13.8M | 7M | 11.8M | 17M | 13.9M | 12.1M | 5.3M | 9M | 3.2M | 1.9M | 27.2M | 5.6M | |
-432.8M | -359.2M | -79.8M | -209.3M | -380.6M | -271.2M | -109.2M | -188.2M | -99.1M | -94.9M | -120.6M | -137M | -104.6M | -59.6M | -152.1M | -112.8M | -29.2M | -84.8M | -92.2M | -98.7M | |
CASH FLOW SUMMARY | ||||||||||||||||||||
-103.8M | -85.6M | 189.8M | 41.2M | -129.8M | 156.5M | 1.3M | -6.3M | -4.2M | 583K | 595K | -70.3M | 14.9M | 31.5M | -11.8M | -62.5M | 108.8M | -1.4M | -24.3M | -27.9M | |
178.4M | 264M | 74.1M | 32.9M | 162.7M | 6.2M | 4.8M | 11.1M | 15.3M | 14.7M | 14.1M | 84.4M | 69.5M | 38.1M | 49.9M | 112.4M | 3.6M | 5M | 29.3M | 57.1M | |
74.5M | 178.4M | 264M | 74.1M | 32.9M | 162.7M | 6.2M | 4.8M | 11.1M | 15.3M | 14.7M | 14.1M | 84.4M | 69.5M | 38.1M | 49.9M | 112.4M | 3.6M | 5M | 29.3M | |
325.5M | 368M | 273.4M | 252.6M | 249.9M | 430.5M | 248.2M | 234.3M | 98.2M | 95.6M | 127.4M | 66.7M | 121.5M | 96.5M | 144.8M | 60.4M | 139.3M | 86M | 72.9M | 76.6M |
SEC Filings
CHE - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 19, 2026 | May 18, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 28, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 23, 2026 | April 23, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 13, 2026 | April 10, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 06, 2026 | December 31, 2025 | 2025 | |
10-K 10-K 2025 FY FY | February 27, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 25, 2026 | February 25, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | October 31, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 28, 2025 | October 28, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | July 31, 2025 | June 30, 2025 | 2025 |
Related Guides
Continue your CHE research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.